C5891130
influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax 2024-2025]
Concept
Cross-maps
Source vocabularies
Atoms not loaded for this concept.
Related concepts
Common questions
What is the UMLS CUI for influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax 2024-2025]?
influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax 2024-2025] is coded as C5891130 in UMLS.
What is UMLS code C5891130?
C5891130 is the UMLS identifier for influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax 2024-2025]. It is included in the current NLM UMLS Metathesaurus release.
What is the RxNorm mapping for C5891130?
C5891130 maps to RxNorm 2688136.